Cancer is still one of the world's deadliest health concerns. As per latest statistics, lung,
breast, liver, prostate, and cervical cancers are reported topmost worldwide. Although …

Cancer continues to be one of the most common causes of mortality globally, claiming
approximately eight million lives each year. Chemotherapy is the primary treatment protocol; …

Cancer is a severe health issue, and cancer cases are rising yearly. New anticancer drugs
have been developed as our understanding of the molecular mechanisms behind diverse …

The use of conventional methods for the treatment of cancer, such as chemotherapy or
radiotherapy, and approaches such as brachytherapy in conjunction with the unique …

Recently, the role of starch-based carrier systems in anticancer drug delivery has gained
considerable attention. Although there are same anticancer drugs, difference in their …

Paclitaxel, a clinical chemotherapy drug commonly used in the past few years, is greatly
limited by its low therapeutic index. Starch and its derivatives have gained wide interest from …

There is a growing appeal for engineering drug delivery systems for controlled and local
drug delivery. Conjugation of antibodies on the nanocarriers for targeted chemotherapeutic …

The diversity of cyclodextrins and their derivatives is increasing with continuous research. In
addition to monomolecular cyclodextrins with different branched chains, cyclodextrin-based …

Colorectal cancer (CRC) is the third most diagnosed cancer type globally and ranks second
in cancer-related deaths. With the current treatment possibilities, a definitive, safe, and …

The physicochemical properties (size, shape, zeta potential, porosity, elasticity, etc.) of
nanocarriers influence their biological behavior directly, which may result in alterations of …